A major pharmaceutical manufacturer has commissioned market research to help improve its communications directed toward Renal Cell Carcinoma (RCC) patients.
Your participation in this research project can help ensure that the company’s brochure and other materials are relevant to patients’ concerns and expressed in a clear and comprehensible way.
Fieldwork, an independent healthcare research and consulting firm located in the U.S., has been engaged to conduct these research interviews on pharmaceutical manufacturer’s behalf. The research project consists of a one-time telephone interview lasting 60 minutes.
The research project is open to patients who had RCC, received a nephrectomy and were non-metastatic at the time of surgery. Please note that space is limited and the research project enrollment will be filled on a first-come, first-served basis.
The research will not require any special preparation by patients, and it will be conducted in strict accordance with all pertinent privacy laws and regulations, including maintaining participants’ confidentiality. Internet access or email access will be required.
In appreciation of your time and valuable contribution, you will receive an honorarium of $150 payable upon successful completion of the telephone interview.
For more information on how you may participate in this important research project please contact: